a strong trendP =0.0535
For example, herein, we observed increased RV degeneration and vasculopathy, with a strong trend ( P =0.0535) for increased RV inflammation, in sitagliptin‐treated SHHF.
For example, herein, we observed increased RV degeneration and vasculopathy, with a strong trend ( P =0.0535) for increased RV inflammation, in sitagliptin‐treated SHHF.